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Association between silent Atrial Fibrillation and heart failure after
Acute Myocardial infarction
Karim Stamboul, A. Gudjoncik, Luc Lorgis, Claude Touzery, Jean Claude
Beer, Marianne Zeller, Yves Cottin
CHU Dijon, USIC, Dijon Cedex, France
Atrial Fibrillation (AF) complicating an acute myocardial infarction (AMI)
is frequent and associated with a worse prognosis after MI, particularly
because of lethal heart failure (HF) episodes and cardiogenic shock. Although
silent AF has also been suggested to be common in AMI, its association with
development of heart failure during the first days after AMI remains unknown.
In this study we aimed to assess a potential association between silent AF and
episodes of heart failure after AMI.
Methods: For AF screening, 581 consecutive AMI were prospectively ana-
lyzed by Continuous ECG Scope Monitoring (CSM) for 48H after hospital
admission. Left Ventricular Ejection Fraction (LVEF) was determined on
admission by echocardiography. We analyzed the study population into
3 groups: No AF, silent AF (asymptomatic episodes of AF lasting at least
>30 sec) and symptomatic AF (symptomatic episodes of AF that lasted
≥12 hours). Diagnosis of heart failure episode was based on plasmatic level of
Nt-ProBNP.
Results: Ninety-five (16.4%) patients had AF on CSM after MI, of whom
76 (80%) developed silent AF. Compared with No AF group, patients with
silent AF were markedly older (80 (69-85) vs 62 (53-74);p<0.001), more fre-
quently women (45 vs 27%;p=0.006), hypertensive (76vs52%;p<0.001) but
less smoker (18vs38%;p<0.001). On admission, patients with silent AF had
animpaired LVEF (46%(13) vs 54%(11);p<0.001), with higher Nt-ProBNP
(1817 (556-7078) vs435 (111-1512);p<0.001) and more frequent episode of
heart failure (42 vs21%;p<0.001).Comparing the three groups, heart failure
episodes during the acute phase after myocardial infarction were more fre-
quent in silent AF group (42%) and in symptomatic AF group (53%)than in
noAF group (21%), with p<0.001.
Conclusion: This studyshows that silent AF is very common after MI
(16.4%), and highlights for the first time that itis significantly associated with
episodes of heart failure. This outcome suggests the potential impact of silent
AF on the prognosis of patients after AMI.
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Long-term follow-up after implantable cardioverter defibrillator in
patients with Brugada syndrome: a multicenter French experience
Aimé Bonny (1), Amara Walid (2), Hasnaa Salih (2), Joelci Tonet (3),
Stéphane Dennetierre (1), Guy Fontaine (3), Robert Frank (3), Françoise
Hidden-Lucet (3)
(1) CH Roubaix, Roubaix, France – (2) CH Montfermeil, Montfermeil,
France – (3) Hôpital Pitié-Salpêtrière, cardiologie, unité rythmologie,
Paris, France
Background and objective: Implantation of a cardioverter defibrillator
(ICD) is a frequently recommended treatment for symptomatic Brugada syn-
drome (BrS). However, complications related to the device have been
reported.
Methods and results: We assessed the benefit / morbidity ratio of this
mode of therapy in a cohort of 34 patients implanted in 3 French experienced
centers between January 1, 2002 and November 30, 2010. The mean age was
48±14 years, 4 (12%) female. Twenty nine (85%) patients had spontaneous
typical coved Type I ECG pattern, 15 (44%) had family history of sudden car-
diac death (SCD) and 24 (88%) had positive EP study. ICD implantation was
based on aborted sudden cardiac arrest (SCA) in 3 (9%), syncope in 19 (56%)
or high risk status (spontaneous type 1 ECG in conjunction with a family his-
tory of SCD and/or a positive EP study) in 12 (35%). The median follow-up
period was 74±23 (9-127) months. One patient with prior cardiac arrest died
of a non-cardiac cause, 5 (15%) patients had appropriate device therapy; all
with spontaneous type I ECG and previous syncope but none with prior car-
diac arrest. Overall complication rate was 26%. Six (27%) symptomatic and 3
(25%) asymptomatic patients experienced complications. Five (14%) patients
(4 with previous syncope and 1 asymptomatic) experienced inappropriate
shocks and 4 (12%) had other complications: 2 patients had lead rupture,
1 lead displacement, and 1 pneumothorax during device replacement. These
complications occurred in 2 asymptomatic and 2 symptomatic (1 syncope and
1 prior aborted SCA) patients. No case of SCD was observed in ICD carriers.
Conclusion: Appropriate device therapy after a median follow-up period
of 6 years was observed in patients with prior syncope and none in asymptom-
atic patients. Complication rate was leading not to recommend ICD implanta-
tion in asymptomatic Brugada patients and to carefully evaluate the risk /
morbidity ratio in subject with non spontaneous coved type ECG pattern.
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Interplay between right ventricular function and cardiac resynchroni-
sation therapy: An Analysis of the CARE-HF trial
Thibaud Damy (1), Stefano Ghio (2), Alan Rigby (3), Luc Hittinger (4),
Sarah Jacob (5), Luigi Tavazzi (6), John Cleland (3)
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lie – (3) Castle Hill Hospital, Academic Cardiology, Kingston-Upon-Hull,
Royaume-Uni – (4) CHU Henri Mondor, UF insuffisance cardiaque
8e étage, Créteil, France – (5) Medtronic Research Centre, Maastricht,
France – (6) GVM Hospitals of Care and Research, Cotignola, Italie
Background: Cardiac resynchronization therapy (CRT) prolongs survival
in appropriately selected patients with heart failure. Right ventricular (RV)
dysfunction is associated with a worse prognosis in this setting but it is not
clear whether it influences the clinical response to CRT.
Method and Results: Of 813 patients enrolled in the Cardiac Resynchro-
nization-Heart Failure (CARE-HF) study, 688 had tricuspid plane systolic
excursion (TAPSE) measured at baseline and 345 of these were assigned to
CRT. Their median (IQR) age was 66 (58-71) years, left ventricular (LV)
ejection fraction was 24 (21-28)% and TAPSE was 19 (16-22)mm. Baseline
LV function and size and QRS duration were similar amongst TAPSE tertiles
but those in the worst tertile (TAPSE<17.4 mm) had higher plasma concentra-
tions of amino-terminal pro-brain natriuretic peptide (NT-proBNP) and were
more likely to have ischaemic heart disease. In response to CRT, patients in
the lowest tertile of TAPSE had less LV reverse remodelling but greater
reductions in NT-proBNP and pulmonary artery pressure and more RV
reverse remodelling compared to other tertiles. The median (IQR) follow-up
for mortality was 748 (582-950) days during which 213 deaths occurred.
Patients with lower TAPSE had a higher mortality regardless of assigned
treatment (p<0.001). Greater inter-ventricular mechanical delay, New York
Heart Association class, mitral regurgitation and NT-proBNP, lower TAPSE
and assignment to the control group were independently associated with
higher mortality. Reduction in mortality with CRT was similar in each tertile.
Conclusion: RV dysfunction is a powerful determinant of prognosis
amongst candidates for CRT, regardless of treatment assigned: CRT improved
prognostic in patients with RV dysfunction despite less improvement in LV
remodelling.
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Reverse electrical remodeling by cardiac resynchronization therapy:
prevalence and clinical impact
Frédéric Sebag (1), Raphael P Martins (1), Pascal Defaye (2), Françoise
Hidden-Lucet (3), Philippe Mabo (1), Jean-Claude Daubert (1), Christophe
Leclercq (1)
(1) CHU Rennes, service de cardiologie et maladies vasculaires, Rennes,
France – (2) Hôpital Michalon CHU Grenoble, Grenoble, France –
(3) Institut de cardiologie; CHU Pitié Salêtrière, Paris, France
Background: Cardiac resynchronization Therapy (CRT) improves left
ventricular ejection fraction (LVEF) in patients with congestive heart failure,
LV systolic dysfunction and a wide QRS complex. Previous reports suggest
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that CRT may also induce electrical remodeling but the impact on clinical out-
come remains unknown. 
Objective: We sought to determine 1) if chronic CRT induces a relevant
shortening of the intrinsic QRS (iQRS), 2) whether changes in the native
conduction system correlate with clinical or echocardiographic response to
CRT and 3) to identify predictors of iQRS width shortening.
Methods: We prospectively included 85 consecutive patients with left
bundle branch block who received a CRT device in 3 French centers. NYHA
class, iQRS duration, LVEF and left ventricular volumes were assessed before
and one year after CRT implantation. Clinical and echocardiographic were
defined respectively as NYHA class improvement >1 class without heart
failure hospitalization and an increase of LVEF by ≥10% and/or a decrease in
LVESV by ≥15%. Electrocardiographic responders were defined as a decrease
in iQRS duration by ≥20 msec.
Results: Baseline and 1-year follow-up mean iQRS durations were respec-
tively 168.0±19.7 ms and 149.6±31.6 ms (p<0.0001). Electrocardiographic
response, observed in 43/85 patients (51%), was associated with a greater rate
of clinical (p=0.035) and echocardiographic (p=0.023) response. Younger age,
male gender and longer baseline QRS width were independent predictors of
electrocardiographic response.
Conclusion: CRT decreases iQRS duration. A reduction of at least 20 ms
in iQRS duration is associated with better clinical and echocardiographic
response.
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Remote monitoring follow-up of 533 ICD/CRT-D recipients: a very
low rate of inappropriate shocks
Pascal Defaye, Romain Cassagneau, Natacha Pellet, Charlotte Vandeneynde,
Alix Martin, Radu Moisei, Peggy Jacon
CHU Grenoble, Unité de rythmologie, Grenoble, France
Remote monitoring (RM) is now accepted as a safe alternative to standard
follow-up (sFU) for ICD recipients (ICDr). 
Methods: We analysed the long term outcomes of 533 ICD/CRT-Dr.
Patients were equipped with Boston Scientific Latitude (45%), Medtronic
Carelink (43%), St Jude Medical Merlin (9%) or Biotronik Home Monitoring
(3%) RM systems. Automatic FU with RM was performed every 3 months,
with at least one sFU /year. In emergency cases patients were invited visits.
ICD programming was done with 2 zones (VT zone>180 bpm / VF
zone>220 bpm). All RM alerts and related EGMs as well as the reasons and
therapies were reviewed by two physicians.
Results: We enrolled 533 pts (82% male, mean age 66±10 y.o.). 55%
had ischemic cardiomyopathy, 69% were primary prevention. CRT-D (46%)
and dual chamber (45%) devices were mainly represented. During a RM FU
period of 15±8 months, we noted 8 automatic RM FU and 2 sFU visits/
patient. 23 deaths occurred. 19 patients had major alerts (5 for ICD lead
dysfunction, 1 for ERI, 9 for electrical storm). 2672 non major alerts
occurred and led to multiple diagnoses: in 22 pts early detection of
unknown AF, in 41 CRT-Dr loss of biventricular pacing. 145 ICD dis-
charges occurred in 52 pts. Within the 66 pts with diagnosed AF by RM,
24 were managed with rhythm control strategy (11 cardioversions, 10 AA
drugs introductions, 3 PAF ablations) and 10 (CRT-D) had a rate control
strategy (AV node ablations in 6 and beta blocker in 4). 91 appropriate
(app) ICD discharges (ICDd) occurred in 35 pts (6,5%) of which 10 were
in primary prevention.
A first inappropriate ICDd occurred in 3,1% of the population (17 pts) and
were mostly due to AF (76%). 74 pts had 1205 app ATP (80% successful).
5 pts with high LV impedance detected by RM had lead dislodgement and
underwent reintervention.
Conclusion: In a large monocentric observational study, RM has demon-
strated to be an effective mode of FU for ICDr. Early diagnoses allow rapid
management of pts and are associated with a very low rate of inappropriate
shocks.
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Prevalence of ventricular tachyarrhythmias clustering in ICD treated
patients with ischemic cardiomyopathy
Athanasios G Manolis, Kostas Kouvelas, George Manolis, Chris Maniotis,
Theo Dragios
Hellenic Red Cross Hospital of Athens, Cardiology, Athens, Grèce
Objective: Ventricular tachyarrhythmias clustering (occurrence of >3 sepa-
rate episodes of VT/VF within a 24 h period, each separated by>5 min) in ICD
population remains a serious problem, associated with adverse prognosis. Our
aim was to retrospectively assess the prevalence of VT clustering in primary
and secondary SCD prevention pts and in single, dual and triple chamber ICD
device.
Methods: We studied 360 consecutive pts with ischemic cariomyopathy
who underwent ICD implantation for primary (20%) and secondary (80%)
SCD prevention, over a mean follow-up period of 8 (5 years. Single, dual and
triple chamber ICD was implanted in 29%, 61% and 10% respectively of pts.
Stored endocardial electrograms were used to determine the causative rhythm
disorders provoking ICD activation.
Results: VT arrhythmic clustering was recorded in 43pts (12%).
Concerning primary and secondary prevention pts, the prevalence was 4% and
14% respectively (p<.001). Concerning Single, Dual and Triple chamber
device, the prevalence was 12,5%, 11,9% and 12,1% respectively (p=NS).
Conclusions: Clustering of VTachyarrhymias occurs more often in
secondary than in primary prevention ICD’s pts with coronary artery disease.
No differences exist between single, dual or triple chamber device.
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Cardiac resynchronization device implantation procedure in real life.
The French Electra survey
Jerome Taieb (1), Maxime Guenoun (2), Arnaud Lazarus (3), Jacques
Mansourati (4), Jean Pierre Cebron (5), Frederic Fossati (6), Marilou
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Introduction: Cardiac resynchronization therapy (CRT) has been a major
breakthrough in cardiac failure management. However, implantation proce-
dure is not standardized.
Aim of the study: To evaluate routine implantation procedure habits in
french practice.
Material and methods: A survey was e-mailed to 100 French CRT
implanters in November 2011. Physicians were interviewed on their own
strategy in the center. Answers had to concern the most frequent routine atti-
tude. If appropriate, physicians could answer “no standardized attitude” or
“other”.
Results: Among the 62 physicians who answered, 45% practise in a uni-
versity hospital, 24% in a non-university hospital and 23% in a private insti-
tution. The rate of physician implantations is <30/year, 30-50/year and
>50/year in 42%, 25% and 33%, respectively. Implantations are performed by
a single operator in 49%, and in 43% by two physicians, 16% of implants
being done under general anaesthesia.
Default CRT-Pacemaker (CRT-P) implantations are right-sided in 18%,
left-sided in 51%, unsettled in 20%, and for CRT-Defibrillator (CRT-D) 8%,
82 and 10% respectively.
The venous approach is “all cephalic” in 21%, “all subclavian” in 18% and
combined in 62%.
First implanted lead is the right ventricular lead (RV) in 74%, and the cor-
onary sinus (CS) lead in 23%. RV lead is placed in apical position in 26% and
in septal position in 67%.
